La Jolla Probability of Target Price Finishing Over 19.6

LJPC -- USA Stock  

Quarterly Earning Report: October 23, 2019  

La Jolla probability of target price tool provides mechanism to make assumptions about upside and downside potential of La Jolla Pharmaceutical Company performance during a given time horizon utilizing its historical volatility. Please specify La Jolla time horizon, a valid symbol (red box) and a target price (blue box) you would like La Jolla odds to be computed. Please see also La Jolla Backtesting, La Jolla Valuation, La Jolla Correlation, La Jolla Hype Analysis, La Jolla Volatility, La Jolla History as well as La Jolla Performance.
Horizon     30 Days    Login   to change
Refresh Odds

La Jolla Target Price Odds to finish over 19.6

Current PriceHorizonTarget PriceOdds to move over $ 19.60  or more in 30 days
 8.40 30 days 19.60 
close to zero percent
Based on normal probability distribution, the odds of La Jolla to move over $ 19.60  or more in 30 days from now is close to zero percent (This La Jolla Pharmaceutical Company probability density function shows the probability of La Jolla Stock to fall within a particular range of prices over 30 days) . Probability of La Jolla Pharmaceutical price to stay between its current price of $ 8.40  and $ 19.60  at the end of the 30-day period is about 85.89 .
Given the investment horizon of 30 days, La Jolla has beta of 0.4269 indicating as returns on market go up, La Jolla average returns are expected to increase less than the benchmark. However during bear market, the loss on holding La Jolla Pharmaceutical Company will be expected to be much smaller as well. Additionally The company has a negative alpha implying that the risk taken by holding this equity is not justified. La Jolla Pharmaceutical is significantly underperforming DOW.
 La Jolla Price Density 
Alpha over DOW
Beta against DOW=0.43
Overall volatility
Information ratio =0.04

La Jolla Alerts and Suggestions

La Jolla generates negative expected return over the last 30 days
La Jolla has high likelihood to experience some financial distress in the next 2 years
The company reported previous year revenue of 17.75 M. Net Loss for the year was (158.26 M) with loss before overhead, payroll, taxes, and interest of (106.49 M).
LA JOLLA PHARMA currently holds about 123.45 M in cash with (118.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.55.
Over 105.0% of the company shares are owned by institutional investors
Latest headline from MacroaxisInsider: Purchase by Kevin Tang of 20000 shares of La Jolla

La JollaPrice Density Drivers

Shares Percent Shares Out16.45%
Short Percent Of Float26.76%
Float Shares14.98M
Average Daily Volume Last 10 Day326.07k
Shares Short Prior Month5.27M
Average Daily Volume In Three Month334.5k
Date Short InterestSeptember 30, 2019